Company: UAA
Filing Date: 2025-06-26
Form Type: DEF 14A
Source: 0001336917-25-000112
Chunk: 13

Company: Under Armour, Inc.
Filing Date: 2025-06-26
Form: DEF 14A
Chunk 13
---
 |               |

<div align='center'>16</div>

| CORPORATE GOVERNANCE AND RELATED MATTERS |

Corporate Governance Highlights

Our Board of Directors has a long-standing commitment to sound and effective corporate governance. Our strong corporate governance practices, including those highlighted below, are codified in our Corporate Governance Guidelines and other key governance documents, and demonstrate the commitment of our Board of Directors to enabling an effective structure to support the successful oversight of our business and long-term objectives:

| ü |     | Separate Chair and CEO                                                                      |
| ü |     | Majority independent Board                                                                  |
| ü |     | Fully independent Board committees                                                          |
| ü |     | Regular executive sessions of non-management directors                                      |
| ü |     | Risk oversight                                                                              |
| ü |     | Full access to management and internal and external auditors                                |
| ü |     | Board and committees have authority to engage independent advisors as they deem appropriate |
| ü |     | Board oversight of succession planning for the CEO and other senior management              |
| ü |     | Annual Board and committee self-evaluation                                                  |

Board Leadership Structure

Our governing documents provide our Board of Directors discretion to combine or separate the positions of Chair and Chief Executive Officer as it may deem appropriate in light of prevailing circumstances. During fiscal year 2025, independent director Mohamed El-Erian served as our Chair of the Board of Directors and Kevin Plank served as our President and Chief Executive Officer and a member of our Board of Directors. We believe the separation of the roles of Chair of the Board and Chief Executive Officer is best suited to the needs of our company at this time. In his capacity as Chair, Dr. El-Erian presides at all meetings of the Board (or selects an interim independent chair to preside over meetings at which he cannot be present), chairs regular executive sessions of the Board without Mr. Plank present, advises on Board meeting agendas and serves as principal liaison between the non-management directors and the Chief Executive Officer, as necessary. In connection with a previously disclosed 2024 settlement agreement, we have further agreed to maintain the separation of these roles for a three-year period.

Independence of Directors

Our Board of Directors currently consists of twelve directors, eleven (92%) of which are independent non-management directors. Karen Katz, who has served as an independent director of our company since 2014, is not standing for reelection at the Annual Meeting. The Board has determined that the following ten directors, each of which is standing for election at our 2025 Annual Meeting,